Skip to content

Ponoi II Management, LLC

Follow

13F filer, CIK 1746488, San Francisco, CA

Ponoi II Management, LLC reported $55,057,000 across 4 holdings for the quarter ended 2021-12-31, in a 13F-HR filed 2022-02-11.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-22-002170

Period
2021-12-31
Reported value
$55.1M
Holdings
4
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NRIXreduced-234,451-$6.79M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2021

Share positions as resolved from 13F-HR 0000950123-22-002170, largest first. % of portfolio is the value over $55,057,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 1,298,908 shares; 2021Q1: 1,298,908 shares; 2021Q2: 1,298,908 shares; 2021Q3: 1,298,908 shares; 2021Q4: 1,298,908 shares 1,298,908$23M41.78%0
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 685,011 shares; 2021Q1: 685,011 shares; 2021Q2: 685,011 shares; 2021Q3: 685,011 shares; 2021Q4: 685,011 shares 685,011$17.2M31.32%0Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 686,274 shares; 2021Q1: 686,274 shares; 2021Q2: 686,274 shares; 2021Q3: 561,574 shares; 2021Q4: 327,123 shares 327,123$9.47M17.2%-234,451Timeline
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 145,401 shares; 2021Q1: 145,401 shares; 2021Q2: 145,401 shares; 2021Q3: 145,401 shares; 2021Q4: 145,401 shares 145,401$5.34M9.7%0

How Q4 2021 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-22-002170 base2022-02-11acceptance time not in the bulk data set